The store will not work correctly when cookies are disabled.
6-(2-(Pyridin-3-yl)ethenyl)-4,5-dihydropyridazin-3(2H)-one
ID: ALA4536976
PubChem CID: 20402500
Max Phase: Preclinical
Molecular Formula: C11H11N3O
Molecular Weight: 201.23
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1CCC(/C=C/c2cccnc2)=NN1
Standard InChI: InChI=1S/C11H11N3O/c15-11-6-5-10(13-14-11)4-3-9-2-1-7-12-8-9/h1-4,7-8H,5-6H2,(H,14,15)/b4-3+
Standard InChI Key: HDYDKRBRUUPOGL-ONEGZZNKSA-N
Molfile:
RDKit 2D
15 16 0 0 0 0 0 0 0 0999 V2000
17.6687 -10.3346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2559 -11.0403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6585 -11.7508 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.4796 -11.7577 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8965 -11.0478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4881 -10.3352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4346 -11.0358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0180 -11.7453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1967 -11.7408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7178 -11.0573 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.7955 -11.0269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9750 -11.0220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5575 -11.7320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9707 -12.4485 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7899 -12.4499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
2 7 1 0
7 8 2 0
8 9 1 0
5 10 2 0
9 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 9 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 201.23 | Molecular Weight (Monoisotopic): 201.0902 | AlogP: 1.36 | #Rotatable Bonds: 2 |
Polar Surface Area: 54.35 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.82 | CX Basic pKa: 4.87 | CX LogP: 0.72 | CX LogD: 0.72 |
Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.79 | Np Likeness Score: -0.88 |
References
1. Ahmed EM, Kassab AE, El-Malah AA, Hassan MSA.. (2019) Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents., 171 [PMID:30904755] [10.1016/j.ejmech.2019.03.036] |